Describing, Diagnosing, & Treatment of Skin, Eye, & Ear Disorders

Full Answer Section

Treatment Modalities: Treatment aims to relieve symptoms, reduce inflammation, and prevent flares.

• Topical Corticosteroids: First-line for reducing inflammation and itching. Potency is chosen based on the location and severity.
• Emollients (Moisturizers): Essential for restoring the skin barrier and reducing dryness, a key factor in many dermatitides.
• Topical Calcineurin Inhibitors (TCIs): Tacrolimus and pimecrolimus are non-steroidal anti-inflammatory agents used for atopic dermatitis, particularly in sensitive areas.
• Antihistamines: Oral antihistamines can help alleviate itching, especially nocturnal pruritus.
• Systemic Corticosteroids: Used for severe flares unresponsive to topical treatment, but long-term use is limited due to side effects.
• Phototherapy: Ultraviolet (UV) light therapy can be effective for certain types of dermatitis, like atopic dermatitis and psoriasis (often considered a distinct condition but with overlapping features).
• Wet Wraps: Can provide relief for severe atopic dermatitis by hydrating the skin and enhancing topical medication absorption.
• Biologics: Newer injectable medications targeting specific inflammatory pathways are used for severe atopic dermatitis refractory to other treatments.
• Avoidance of Triggers: Identifying and avoiding irritants or allergens is crucial for contact dermatitis.

2. Drug Therapy for Conjunctivitis and Otitis Media

Conjunctivitis (Pink Eye): Inflammation of the conjunctiva. Drug therapy depends on the cause:

• Bacterial Conjunctivitis: Topical antibiotics are the mainstay. Common options include fluoroquinolones (ciprofloxacin, ofloxacin), macrolides (erythromycin, azithromycin), aminoglycosides (tobramycin, gentamicin), and trimethoprim-polymyxin B. Treatment duration is typically 5-7 days. In severe cases, oral antibiotics might be considered.
• Viral Conjunctivitis: Usually self-limiting (1-3 weeks). Treatment focuses on symptomatic relief with artificial tears and cool compresses. Antiviral medications (e.g., acyclovir, ganciclovir) are reserved for specific viral causes like herpes simplex or varicella-zoster.
• Allergic Conjunctivitis: Topical antihistamines (e.g., azelastine, olopatadine), mast cell stabilizers (e.g., cromolyn sodium, nedocromil), or dual-action agents are used to reduce itching, redness, and swelling. Topical corticosteroids may be used for severe cases under ophthalmological supervision. Oral antihistamines can also provide systemic relief.

Otitis Media (Middle Ear Infection): Inflammation of the middle ear, commonly caused by bacteria or viruses.

• Acute Otitis Media (AOM):
  • Antibiotics: Amoxicillin is often the first-line antibiotic for uncomplicated AOM. For penicillin-allergic patients or cases with antibiotic resistance risk factors, alternatives include amoxicillin-clavulanate, cefuroxime, ceftriaxone (intramuscular), or azithromycin/clarithromycin (though resistance is a concern). Treatment duration varies by age and severity (typically 5-10 days). Observation without antibiotics may be appropriate in select cases (e.g., mild symptoms in children 6-23 months with unilateral AOM or children ≥2 years with unilateral or bilateral AOM without severe symptoms).
  • Pain Management: Analgesics like acetaminophen or ibuprofen are crucial for pain relief.
  • Decongestants: Oral or nasal decongestants may provide symptomatic relief but are not routinely recommended and have limited evidence of effectiveness.
• Otitis Media with Effusion (OME): Fluid in the middle ear without signs of acute infection. Usually resolves spontaneously. Antibiotics are generally not indicated. Management focuses on observation and monitoring for hearing loss or speech delays.
• Recurrent Otitis Media: Prophylactic antibiotics (low-dose amoxicillin) or tympanostomy tubes (ear tubes) may be considered for children with frequent AOM episodes.

3. Herpes Virus Infections: Patient Presentation and Treatment

Herpes viruses are a family of DNA viruses causing various infections. Common human herpesviruses include Herpes Simplex Virus type 1 (HSV-1), Herpes Simplex Virus type 2 (HSV-2), Varicella-Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV), Human Herpesvirus 6 (HHV-6), and Human Herpesvirus ¹ 8 (HHV-8).  

Patient Presentation (Examples):

• HSV-1 (Oral Herpes): Characterized by cold sores or fever blisters, typically on the lips or around the mouth. Initial outbreaks can be more severe with systemic symptoms. Recurrences are usually milder.
• HSV-2 (Genital Herpes): Presents with painful vesicles and ulcers on the genitals, perineum, or buttocks. Similar to HSV-1, initial outbreaks can be more intense, and recurrences are common.
• VZV (Varicella - Chickenpox): Presents as a widespread, itchy, vesicular rash, often accompanied by fever, malaise, and headache, primarily in children.
• VZV (Herpes Zoster - Shingles): A reactivation of latent VZV in a sensory ganglion, causing a painful, unilateral, vesicular rash along a dermatome. Postherpetic neuralgia (PHN), chronic pain in the affected area, is a significant complication.
• EBV (Infectious Mononucleosis): Characterized by fatigue, fever, sore throat, and lymphadenopathy (swollen lymph nodes), often with splenomegaly.
• CMV: Can be asymptomatic in healthy individuals. In immunocompromised patients, it can cause various organ system involvement (e.g., retinitis, pneumonitis, colitis). Congenital CMV infection in newborns can lead to serious complications.
• HHV-6 (Roseola Infantum): Typically presents in young children with a high fever for several days, followed by a characteristic rose-pink maculopapular rash.
• HHV-8 (Kaposi's Sarcoma-associated Herpesvirus): Primarily affects immunocompromised individuals (especially those with HIV/AIDS), causing Kaposi's sarcoma (vascular tumors of the skin, mucous membranes, and internal organs).

Treatment: Antiviral medications are the primary treatment for many herpesvirus infections:

• Acyclovir: A guanosine analog effective against HSV-1, HSV-2, and VZV. Available in oral, topical, and intravenous formulations.
• Valacyclovir: A prodrug of acyclovir with better oral bioavailability, often preferred for oral treatment of HSV and VZV infections.
• Famciclovir: Another guanosine analog with good oral bioavailability, also effective against HSV and VZV.
• Ganciclovir and Valganciclovir: Primarily used for CMV infections, available in intravenous and oral forms, respectively.
• Foscarnet and Cidofovir: Alternative antivirals for resistant CMV or other herpesvirus infections, administered intravenously.

Treatment strategies vary depending on the specific virus, severity of infection, and patient's immune status. For initial HSV outbreaks, oral antivirals can reduce the duration and severity of symptoms. For recurrent HSV, episodic or suppressive antiviral therapy may be used. For shingles, early treatment with oral antivirals (within 72 hours of rash onset) can reduce the duration of the rash and the risk of PHN. EBV infection is generally self-limiting, and treatment focuses on supportive care. CMV treatment is typically reserved for symptomatic or immunocompromised individuals. HHV-6 infection is usually benign and requires only symptomatic management. Kaposi's sarcoma treatment depends on the extent of the disease and the patient's immune status, often involving antiretroviral therapy for HIV-positive individuals and potentially chemotherapy, radiation, or local therapies.

Sample Answer

Dermatitis: Description, Diagnostic Criteria, and Treatment Modalities

Dermatitis is a general term describing inflammation of the skin, resulting in various patterns of rash. Common symptoms include itching, redness, swelling, and the formation of blisters, scales, or crusts. Different types exist, including atopic dermatitis (eczema), contact dermatitis (allergic or irritant), seborrheic dermatitis, and stasis dermatitis.

Diagnostic Criteria: Diagnosis is primarily clinical, based on history (onset, triggers, associated symptoms), physical examination (location, morphology, distribution of lesions), and exclusion of other conditions. Patch testing may be used for suspected allergic contact dermatitis. Biopsy is sometimes necessary for atypical presentations or to rule out other diagnoses.